Contact
Please use this form to send email to PR contact of this press release:
uniQure Announces First Two Patients Treated in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
TO:
Please use this form to send email to PR contact of this press release:
uniQure Announces First Two Patients Treated in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
TO: